Cyroablation for Pulmonary Vein Isolation Alone in Patients with Early Persistent AF Assessed by Continuous Monitoring

NCT05507749 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2024-11-06

No results posted yet for this study

Summary

This study aimed to evaluate the efficacy of Cryoablation in patients with early persistent atrial fibrillation as a first index procedure using continuous cardiac rhythm monitoring.

Conditions

  • Atrial Fibrillation, Persistent

Interventions

PROCEDURE

cryoballoon ablation

Cryoballoon ablation for the treatment of atrial fibrillation

DEVICE

implantable loop recorder insertion

The device called a implantable loop recorder, is placed just under the skin of one's chest during a minor surgery.

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER
  • Samsung Medical Center

    collaborator OTHER
  • Hallym University Medical Center

    collaborator OTHER
  • Asan Medical Center

    collaborator OTHER
  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Eue-Keun Choi, M.D. Ph.D. · Seoul National University Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-27
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05507749 on ClinicalTrials.gov